Gleneagle targets biotech

09/12/2015 - 10:49

Bookmark

Upgrade your subscription to use this feature.

Gleneagle Gold will make a second attempt at a reverse takeover with plans to buy a local unlisted medical cannabis company in a deal worth about $8 million.

To read our articles you will need to either login or subscribe.

STANDING BY BUSINESS. TRUSTED BY BUSINESS.

Subscription Options